Pre-existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation

Clinical Transplantation

Volumn 27, Issue 2, 2013, Pages 274-282

  Taber, David J ^a   Meadows, Holly B ^b   Pilch, Nicole A ^b   Chavin, Kenneth D ^a   Baliga, Prabhakar K ^a   Egede, Leonard E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Acute rejection; Cardiovascular disease; Diabetes; Glycemic control; Graft survival; Kidney transplantation; Patient survival

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BASILIXIMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DACLIZUMAB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DELAYED GRAFT FUNCTION; DIABETES MELLITUS; DRUG DOSE TITRATION; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; GRAFT FAILURE; GRAFT SURVIVAL; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876073307     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12080     Document Type: Article

References (23)

1. Diabetes Statistics. American Diabetes Association. http://www.diabetes.org/diabetes-basics/diabettes-statistics. Accessed February 24, 2012.
2. Scientific Registry of Transplant Recipients. http://www.ustransplant.org. Accessed March 21, 2012.
3. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
4. Kuo HT, Sampaio MS, Vincenti F, Bunnapradist S. Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: An analysis of the organ procurement and transplant Network/United network for organ sharing (OPTN/UNOS) database. Am J Kidney Dis 2010: 56: 1127.
5. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y. Patient survival and cardiovascular risk after kidney transplantation: the challenge of diabetes. Am J Transplant 2008: 8: 593.
6. Liefeldt L, Budde K. Risk factors for cardiovascular disease in renal transplant recipients and strategies to minimize risk. Transplant Int 2010: 23: 1191.
7. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003: 3: 178.
8. Romming Sorensen V, Schwartz Sorensen S, Feldt-Rasmussen B. Long-term graft and patient survival following renal transplantation in diabetic patients. Scand J Urol Nephrol 2006: 40: 247.
9. Reboldi G, Gentile G, Angeli F, Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. Vasc Health Risk Manag 2009: 5: 411.
10. Patel A, Joshi R, de Galan B. Trials of cardiovascular risk factor management in type 2 diabetes. Curr Opin Cardiol 2009: 24: 288.
11. Moritz T, Duckworth W, Abraira C. Veterans affairs diabetes trial-corrections. N Engl J Med 2009: 361: 1024.
12. Mills EJ, Wu P, Chong G et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170, 255 patients from 76 randomized trials. QJM 2011: 104: 109.
13. Martin JH, Mangiafico S, Kelly DJ. Role of statins in diabetes complications. Curr Diabet Rev 2009: 5: 165.
14. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care 2011: 34(Suppl. 1): S11-61.
15. Wilkinson A, Davidson J, Dotta F et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clin Transplant 2005: 19: 291.
16. Boerner BP, Shivaswamy V, Desouza CV, Larsen JL. Diabetes and cardiovascular disease following kidney transplantation. Curr Diabet Rev 2011: 7: 221.
17. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996: 7: 158.
18. ADVANCE Collaborative G, Patel A, MacMahon S et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008: 358: 2560.
19. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008: 359: 1577.
20. Poulter NR. Managing the diabetic hypertensive patient. J Diabet Compl 1996: 10: 141.
21. Landmark K, Reikvam A. [Effects of antihypertensive drugs on glucose metabolism and cardiovascular events]. Tidsskr Nor Laegeforen 2009: 129: 1740.
22. Krupej J, Kedzierski L, Gdula-Dymek A, Krysiak R, Okopien B. [Beta-adrenolitics in therapy of cardiovascular diseases in patients with type 2 diabetes mellitus]. Wiad Lek 2011: 64: 132.
23. Pilmore HL, Skeans MA, Snyder JJ, Israni AK, Kasiske BL. Cardiovascular disease medications after renal transplantation: Results from the patient outcomes in renal transplantation study. Transplantation 2011: 91: 542.